ASND
Ascendis Pharma A/S
NMS
$218.06
+2.46
(+1.14%)
Pullback · -0.53σ
Valuation
Market cap
$14.3B
P/E (ttm)
25.0
Forward P/E
20.0
Beta (5y)
—
Shares out
65.6M
Div yield
—
Profitability & returns
ROE
332.7%
Net margin
57.3%
FCF margin
13.7%
Debt / equity
1.84
Trading information
Last price
$218.06
Day range
$218.06 – $218.06
52-wk range
$188.08 – $250.74
Avg volume
0.6M
RSI (2)
81.4
TAO zone
Pullback
Company
Sector
Healthcare
Industry
Biotechnology
Exchange
NMS
Next earnings
2026-04-30
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipe…